Systematic review of machine learning applications in the early prediction and management of chronic lymphocytic leukaemia
Contact us if these videos are not relevant.
Contact us if these videos are not relevant.
View abstract on PubMed
Summary
This summary is machine-generated.Machine learning (ML) shows promise for Chronic Lymphocytic Leukaemia (CLL) classification and management. Further research requires larger datasets and improved model interpretability for clinical application.
Area Of Science
- Hematology
- Computational Biology
- Medical Informatics
Background
- Chronic Lymphocytic Leukaemia (CLL) management requires accurate classification and prognostication.
- Machine learning (ML) offers potential tools for improving patient outcomes in haemato-oncology.
Purpose Of The Study
- To review the efficacy of ML models in the classification and management of CLL.
- To identify current limitations and future directions for ML applications in CLL.
Main Methods
- A systematic review of 20 studies published between 2014 and 2023.
- Focus on supervised ML models for outcome prediction and treatment guidance in CLL.
- Literature search conducted across PubMed, Google Scholar, and IEEExplore.
Main Results
- All reviewed studies reported positive outcomes, indicating ML's potential to enhance clinical workflows.
- Limitations include small, single-center datasets leading to potential overfitting and reduced generalizability.
- Key areas for advancement include larger, multimodal datasets, improved model interpretability, and NLP for unstructured data.
Conclusions
- ML holds significant transformative potential for CLL patient management.
- Addressing data limitations (size, diversity, multi-institutional) and enhancing model interpretability are critical for clinical translation.
- Innovations like federated learning and automated redaction can mitigate data integration and privacy concerns.
Contact us if these videos are not relevant.
Contact us if these videos are not relevant.